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Abstract: Substance use disorders (SUDs) are a pervasive public health problem with del-
eterious consequences for individuals, families, and society. Furthermore, SUD intervention 
is complicated by the continuous possibility of relapse. Despite decades of research, SUD 
relapse rates remain high, underscoring the need for more effective treatments. Scientific 
findings indicate that SUDs are driven by dysregulation of neural processes underlying reward 
learning and executive functioning. Emerging evidence suggests that mindfulness training can 
target these neurocognitive mechanisms to produce significant therapeutic effects on SUDs 
and prevent relapse. The purpose of this manuscript is to review the cognitive, affective, 
and neural mechanisms underlying the effects of mindfulness-based interventions (MBIs) 
on SUDs. We discuss the etiology of addiction and neurocognitive processes related to the 
development and maintenance of SUDs. We then explore evidence supporting use of MBIs 
for intervening in SUDs and preventing relapse. Finally, we provide clinical recommenda-
tions about how these therapeutic mechanisms might be applied to intervening in SUDs and 
preventing relapse.
Keywords: addiction, mindfulness, reward, relapse, substance use disorders
Introduction
Substance use disorders (SUDs) are a pervasive public health problem with deleterious 
consequences for individuals, families, and society. SUDs are characterized by recurrent 
drug use that results in functional impairment (ie, continuing to use substances despite 
health problems, inability to meet obligations at work, school, or home due to substance 
use).1 SUD includes alcohol, tobacco, and other drug use disorders. According to the 
2016 National Survey on Drug Use and Health,2 15.1 million Americans aged 12 or 
older met criteria for an alcohol use disorder in the past year, whereas 7.4 million met 
criteria for an illicit drug use disorder. Specifically, marijuana use disorder was the 
most prevalent illicit drug use disorder (4.0 million American adults), followed by 
opioid use disorder (2.1 million). In addition to alcohol and illicit drug use, tobacco 
use continues to be the largest preventable cause of death in the United States, killing 
480,000 Americans every year and costing more than $300 billion annually.3
SUDs are associated with medical problems,1 mental health disorders,5 and higher 
rates of suicidal ideation and attempts.6 In 2016, 64,000 Americans died from over-
dose.7 Additionally, SUDs exact a large economic toll, with crime, loss of  productivity, 
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and health care costs due to substance use estimated at more 
than $740 billion annually in the United States.8 The high 
prevalence and devastating impact of SUDs has created an 
urgent need for access to effective interventions to treat 
addiction and prevent relapse. However, of the 21 million 
people needing SUD intervention in 2016, only 3.8 mil-
lion actually received it,2 perhaps as a result of a lack of 
access to healthcare or motivation. For those who receive 
intervention, relapse is all too common. Relapse rates for 
traditional behavioral substance use intervention programs 
(eg, cognitive-behavioral therapy, motivational interviewing, 
and 12-step programs), have been estimated to be as high as 
60% in the year following treatment.9,10 Thus, new interven-
tion options are sorely needed.
Researchers and clinicians have begun to explore 
mindfulness-based interventions (MBIs) for intervening in 
SUDs and relapse prevention. Mounting evidence supports 
the use of MBIs to address psychiatric disorders.11 Building 
on the first-generation MBIs’ (eg, Mindfulness-Based Stress 
Reduction, MBSR12; Mindfulness-Based Cognitive Therapy, 
MBCT13 success in intervening in stress-related conditions 
and affective disorders), newer MBIs like Mindfulness-Based 
Relapse Prevention (MBRP),14 and Mindfulness-Oriented 
Recovery Enhancement (MORE)15 use tailored mindfulness-
based intervention strategies to reduce, stop, and prevent 
substance use. Evidence supporting the efficacy of MBIs 
as an intervention for SUDs and for relapse prevention is 
growing. A recent systematic review from Sancho et al16 
included 54 randomized controlled trials (RCTs) targeting 
either substance or behavioral addictions. Results revealed 
MBIs (eg, MBRP; Mindfulness Training for Smokers, 
MTS; MORE, Acceptance and Commitment Therapy, ACT; 
Yoga) reduced substance dependence and craving, as well as 
other addiction-related symptoms (eg, pain, health-related 
quality of life, depression, and anxiety) through improving 
mood state and emotion dysregulation. Despite promising 
preliminary evidence of MBI efficacy, Sancho et al16 con-
cluded the most effective intervention approach is likely to 
involve combining MBIs with treatment-as-usual (TAU) or 
other active treatments, while also calling for more rigorous 
research designs with longer follow-up periods.
Similar conclusions were reached in Li et al’s17 review of 
34 MBI RCTs for addiction intervention and relapse preven-
tion. Despite significant differences between studies with 
regard to sample demographics, mindfulness and control con-
ditions studied, and outcome measures, Li et al17 found MBI 
involvement (eg, brief, laboratory-based mindfulness induc-
tions, MTS, MORE, Mindfulness Integrative  Body-Mind 
Treatment) resulted in significantly greater improvement at 
post-treatment and follow-up assessments than comparator 
conditions in the majority of trials. Meta-analytic findings 
revealed effect sizes (ie, Cohen’s d and odds ratios [ORs]) 
ranged from small to large for substance use, stress, and 
craving outcomes. Of the 34 RCTs in the meta-analysis, 19 
included participants who were actively engaged in substance 
use (eg, tobacco use disorder, alcohol use disorder and at-risk 
alcohol use behavior, cocaine use disorder, marijuana use 
disorder, opioid misuse). Of those 19 RCTs, 15 RCTs found 
mindfulness significantly reduced substance use relative to 
controls,18–32 and five RCTs found mindfulness significantly 
reduced craving compared to the control condition.19,20,31,33,34 In 
addition, Li et al17 reviewed studies of mindfulness for relapse 
prevention. Fifteen of the included RCTs studied mindfulness 
as a relapse prevention strategy, with six RCTS reporting 
mindfulness (eg, MBRP, MORE, and Mindful Awareness in 
Body-Oriented Therapy) significantly reduced substance use 
compared to a control group21,35–39; four reported mindfulness 
reduced craving relative to controls,21,40–42 and two reported 
reductions in relapse risk.36,43
With accumulating evidence supporting the efficacy of 
MBIs, the purpose of this paper is to review the cognitive, 
affective, and neural mechanisms underlying the effects of 
MBIs on SUDs. Here we also provide clinical recommen-
dations about how these therapeutic mechanisms might be 
applied to intervening in SUDs and preventing relapse. In 
this review, we first briefly discuss the etiology of addiction 
and neurocognitive processes related to the development 
and maintenance of SUDs. We then discuss how mindful-
ness training intervenes in SUDs and prevents relapse, and 
review evidence of the mechanisms and efficacy of MBIs for 
intervening in substance use and preventing relapse.
A neurocognitive perspective on the 
etiology of SUDs
Alcohol and drug use disorders may be understood through 
a 3-stage cycle of addiction: preoccupation/anticipation, 
binge/intoxication, and withdrawal/negative affect.44 This 
cycle creates allostatic neuroadaptations in the brain’s reward 
and stress systems, which ultimately lead to decreased 
responsiveness to natural rewards, increased sensitivity to 
stress, and automatic, conditioned responses to drug cues 
that drive substance use behavior. Initially, dopamine release 
in the brain’s reward system (ie, ventral striatum and ventral 
tegmental area)45–48 positively reinforces substance use, which 
facilitates associative learning.48 As a result of this Pavlovian 
conditioning, the rewarding, euphoric experiences occasioned 
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by substance use are associated with environmental cues 
contemporaneous with substance use (eg, specific settings 
where the substance has been used, people the substance 
has been used with, or negative emotional states preceding 
substance use). Over time, greater quantities of dopamine 
are released in response to these conditioned environmental 
stimuli (ie, substance cues) than are produced by the phar-
macologic properties of the substance; this cue-dependent 
dopamine release results in craving for the substance,49 
substance-seeking behavior, and binge substance use.50–52 
Though dopamine release will decrease in response to satia-
tion of a natural reward (eg, food, sex, or social interaction), 
drug cue-elicited dopamine levels continue to rise as a result 
of recurrent substance use, leading to “automaticity” – the 
habitual use of substances triggered by substance cues. Over 
time, recurrent substance use results in neuroplastic changes 
that render natural rewards (eg, food, sex, social interactions) 
less reinforcing. This desensitization to natural rewards, or 
“hedonic dysregulation,” leads to a reduced capacity to feel 
pleasure and reduced motivation to pursue healthful and 
socially affiliative activities as reward and motivation circuits 
are hijacked by the drive to seek and consume substances.
Exacerbating this process of addictive automaticity and 
hedonic dysregulation, chronic substance use also dysregu-
lates key nodes in neural circuits underlying executive func-
tioning, such as the anterior cingulate cortex (ACC) and the 
dorsal and ventrolateral prefrontal cortex (PFC).53 Substance 
misuse weakens functional connectivity between these cogni-
tive control regions and striatal networks implicated in reward 
processing and motivation, changes that are associated with 
blunted positive affect, elevated craving, and higher risk of 
relapse.54,55 Such dysconnectivity between cognitive control 
and reward systems may thereby contribute to compulsive 
drug seeking and consumption. Further, chronic substance 
use also produces maladaptive neuroplasticity in brain stress 
circuitry (eg, the extended amygdala). As a result, individuals 
with substance use disorder come to experience “increased 
reactivity to stress and negative emotion.”56,57 Gradually, a 
person may become dependent on substances as a means 
of regulating the dysphoria and anxiety stemming from 
increased stress reactivity, ensnaring them deeper into the 
cycle of addiction.
These neurocognitive processes contribute to craving 
and elicit substance use behavior long after an individual 
has stopped using substances. Even when total abstinence 
is achieved, substance-related cues and negative emotional 
states can continue to trigger relapse.50,58 Thus, interventions 
are needed to target the manifold processes undergirding 
 substance use disorder and relapse. MBIs hold special 
promise in that regard.
Mindfulness meditation (MM)
Mindfulness training is a promising intervention option 
for SUDs and relapse prevention.17,59 Mindfulness can be 
conceptualized as a state, trait, and practice.60 The state of 
mindfulness is cultivated during mindfulness practice and 
is characterized by a non-judgmental, non-reactive, present-
centered attention and metacognitive awareness of cognition, 
emotion, sensation, and perception.61,62
Two primary mindfulness practices are focused attention 
and open monitoring. Focused attention meditation practice 
involves attending to an object (eg, the sensation of breath-
ing or walking, parts of the body, or visual stimuli) while 
acknowledging and letting go of distractions.60 Open monitor-
ing meditation practice involves maintaining a metacognitive 
stance in which the practitioner remains cognizant of both 
the field of awareness and the flux of internal and external 
stimuli (eg, thoughts, sensations, emotions, perceptions) aris-
ing within that field, without fixating on any specific object 
of attention.60 These practices are often combined during a 
single meditation session.
As repeated mindfulness practice evokes the state of 
mindfulness, MBI participants exhibit increases in trait 
mindfulness over time.63,64 Trait mindfulness may be defined 
as the tendency to exhibit mindful qualities in daily life, 
including nonreactivity to distressing thoughts and emo-
tions, as well as the tendency to observe and accept one’s 
momentary thoughts, feelings, perceptions, and sensa-
tions.65,66 So, beyond the context of acute mindful states, 
mindful traits may decrease cognitive, emotional, and 
behavioral tendencies that help sustain substance misuse. 
Indeed, trait mindfulness has been found to be positively 
associated with heightened executive control function-
ing,67–69 and small but statistically significant negative cor-
relations have been found between trait mindfulness and 
craving,70 as well as substance use.71 As individuals with 
SUDs engage in mindfulness practices within MBIs, they 
learn to cultivate trait mindfulness, providing a bulwark 
against substance use and relapse.
Methods
We conducted a literature search in PubMed, PsychInfo, and 
Web of Science. We then searched reference lists of included 
studies. We did not search gray literature. We included 
the following search string: mindfulness OR mindfulness 
intervention OR mindfulness-based relapse prevention OR 
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mindfulness-based stress reduction OR mindfulness-based 
cognitive therapy AND substance* use OR alcohol use OR 
drug use OR cocaine use OR opioid use OR tobacco use OR 
marijuana use AND mechanism OR neurocognitive. From 
this search we found 31 relevant records in PubMed, 56 in 
PsychInfo, and 117 in Web of Science. We included studies 
which were experimental and quasi-experimental in nature 
(see Figure 1).
Results
After reviewing the studies, we included 21 studies in the 
qualitative synthesis. We grouped these studies into three 
primary domains – promoting cognitive control or executive 
functioning (see Table 1), restructuring reward (see Table 2), 
and decreasing stress reactivity (see Table 3).
Promoting cognitive control over 
automaticity
Therapeutic effects of MBIs on substance use and relapse pre-
vention may be mediated by the effects of mindfulness train-
ing on neurocognitive mechanisms implicated in addiction. 
From a mechanistic perspective, MBIs have been construed 
as mental training programs designed to exercise neurocogni-
tive capacities that go awry during the process of addiction.72 
Figure 1 PRISMA flow diagram.
Note: PLoS Medicine (OPEN ACCESS) Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097.109
Abbreviations: SUD, substance use disorder; RCT, randomized controlled trials.
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through other sources
(n = 12)
Records after duplicates removed
(n =141)
Records screened
(n = 141)
Records excluded
(n = 89)
Full-text articles assessed
for eligibility
(n = 52)
Full-text articles excluded (n = 40)
Primary reasons for exclusion: 
No mindfulness intervention (n = 2)
No underlying neurocognitive 
mechanism (n = 16)
Not studying SUD (n = 12)
Not a RCT design (n = 5)
Review article (n = 5)
Studies included in
qualitative synthesis
(n = 12)
Hence, the focused attention and open monitoring medita-
tions integral to MBIs can been conceptualized as exercises 
for strengthening prefrontally-mediated brain circuits integral 
to cognitive control – circuits whose functions are disrupted 
by chronic drug use and usurped by drug-related cues dur-
ing the development of addiction. Cultivation of increased 
cognitive control capacity through mindfulness practices can 
allow the individual to gain self-control over automatic sub-
stance use behavior. This therapeutic process is theorized to 
involve increasing functional connectivity between prefrontal 
control regions and striatal brain circuitry involved in reward 
processing and habit responses.72 Improved communication 
in this frontostriatal circuit may provide the means by which 
MBIs can restructure reward processes hijacked during the 
addictive process.73 In this way, MBIs may strengthen a 
domain-general neurocognitive resource that can be used to 
modulate the automaticity, hedonic dysregulation, and stress 
reactivity that undergirds SUDs and relapse. Evidence for 
these mechanisms is reviewed below.
Multiple domains of investigation suggest that meditation 
practice promotes executive functioning and cognitive control 
over automatic habits. Behavioral studies have found that 
meditation decreased automatic responses on a Stroop task74 
and habitual cognitive scripts.75 With respect to addiction, a 
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Table 1 Experimental studies of the impact of mindfulness on executive functioning
Study SUD/addictive 
behavior (sample size)
MBI Control condition Results
Alfonso 
et al76
Alcohol and polysubstance 
use disorder (N=34)
Goal management training + 
Mindfulness
Standard treatment Participants enrolled in GMT + mindfulness 
demonstrated significant improvement 
in performance on neuropsychological 
measures of working memory, response 
inhibition, and decision-making when 
compared to standard treatment.
Garland 
et al79
Opioid-misuse among 
chronic pain patients 
(N=115)
MORE (eight 2-hour group 
sessions)
Support group (eight 
2-hour group sessions)
MORE participants demonstrated a 
decrease in opioid attentional bias when 
compared to support group participants.
Tang 
et al110
Tobacco use disorder 
(N=60)
IBMT: 30-minutes practice 
training every night for 10 
consecutive nights
Relaxation training: 
30-minutes practice 
training every night for 
10 consecutive nights
Participants in the IBMT reported more 
efficacy in regulating emotions which were 
related to increased ACC/medial prefrontal 
cortex (mPFC) activity.
Valls-
Serrano 
et al77
Polysubstance use 
disorder (N=32)
GMT + MM + TAU TAU Participants assigned to the GMT + 
MM condition demonstrated significant 
increases in reflective processes compared 
to TAU participants.
Abbreviations: SUD, substance use disorder; MBI, mindfulness-based interventions; GMT, goal management training; MORE, mindfulness-oriented recovery enhancement; 
IBMT, integrative body-mind training; ACC, anterior cingulate cortex; MM, mindfulness meditation; TAU, treatment-as-usual; mPFC, medial prefrontal cortex.
Table 2 Experimental studies of the impact of mindfulness on reward
Study SUD/addictive 
behavior (sample size)
MBI Control condition Results
Froeliger et al89 Tobacco use disorder MORE (ten 
2-hour 
sessions)
No treatment Compared to the comparison group, MORE 
participants demonstrated decreased BOLD 
response in ventral striatum (vs) and ventral 
prefrontal cortex (vPFC) during a craving 
regulation task and increased positive BOLD 
signal in vs and vPFC during an emotion regulation 
task.
Garland et al86 Opioid misuse among 
chronic pain patients 
(N=69)
MORE: 8 
weekly, 2-hour 
group sessions
Support Group: 8 weekly, 
2-hour, therapist-led social 
support groups based on 
the Matrix model IOP 
treatment manual
MORE participants demonstrated significantly 
greater reductions in opioid cue-reactivity on 
the dot probe task, enhancement in heart rate 
deceleration during attention to pleasure cues, 
and increases in HR variability from rest during 
emotional attention to pleasure cues.
Carroll et al96 Opioid misuse among 
chronic pain patients 
(N=29)
MORE: 8 
weekly, 2-hour 
group sessions
Support Group: 8 weekly, 
2-hour group sessions
Participation in MORE was associated with 
significant increases in LPP response to natural 
reward stimuli relative to neutral stimuli.
Kober et al98 Alcohol use disorder 
(N=53)
MORE: 10 
weekly, 2-hour 
group sessions
Support Group: 10 
weekly, therapist-led 
social support groups 
based on the Matrix 
model IOP tx manual
MORE participants demonstrated a significantly 
greater reduction in alcohol attentional bias and 
improvement in physiological recovery from 
alcohol cues after treatment when compared to 
support group participants.
Paz et al97 Opioid misuse among 
chronic pain patients 
(N=51)
MORE: 8 
weekly, 2-hour 
group sessions
Support Group: 8 weekly, 
2-hours group sessions
Compared to the support group, MORE 
participants demonstrated significantly greater 
increases in responsiveness to natural reward 
cues relative to drug cues.
Abbreviations: SUD, substance use disorder; MBI, mindfulness-based interventions; MORE, mindfulness-oriented recovery enhancement; BOLD, blood oxygen level 
dependent; LPP, late positive potential; IOP, intensive outpatient treatment.
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quasi-experimental study found that mindfulness training 
among polysubstance using individuals led to significant 
improvements in working memory, selective attention/
response inhibition, and decision-making skills when com-
pared to a TAU control condition.76 A pilot RCT replicated 
these findings,77 demonstrating that a combination of goal 
management and mindfulness training improved executive 
function. A small RCT found that smokers who participated 
in 2 weeks of mindfulness training demonstrated increased 
resting state activation in prefrontal and ACC regions 
involved in cognitive control, neural changes that were cor-
related with decreases in smoking.18 This evidence supports 
the idea that mindfulness training may decrease substance 
use behavior by increasing activation in prefrontally-mediated 
cognitive control networks and thereby facilitate regulation of 
reactivity to substance cues. In that regard, mechanistic data 
from a stage 2 RCT for prescription opioid misuse found that 
MORE significantly decreased subjective and autonomic cue-
reactivity,78 as well as attentional bias, toward opioid cues.79
Restructuring reward
Mindfulness training has also been shown to enhance hedonic 
experience and positive emotion80–82 by cultivating focused 
attention on natural rewards – a practice called “savoring.”15,83 
For example, a brief mindful eating practice increased food 
liking and enjoyment, while another study found an 8-week 
mindfulness intervention increased participants’ experiences 
of reward while engaging in pleasant daily life activities.84 
These studies contribute to the growing body of evidence sup-
porting the “restructuring reward hypothesis,” which suggests 
that mindfulness addresses hedonic dysregulation by increas-
ing natural reward responsiveness, thereby reducing craving 
and substance use behavior.82 In support of this hypothesis, 
a RCT of opioid-misusing chronic pain patients found eight 
weeks of MORE increased heart rate variability (HRV) and 
electrocortical responses to naturally-rewarding images, and 
these psychophysiological markers were associated with 
decreased opioid craving.85,86 In addition, MORE increased 
autonomic responses to naturally-rewarding stimuli relative 
to opioid-related stimuli, and increases in this measure of 
relative cardiac responsiveness predicted reduced opioid 
misuse at a 3-month follow-up.87 Ecological momentary 
assessment data collected during this trial supported these 
psychophysiological findings, indicating MORE increased 
moment-to-moment positive affect, which predicted 
decreases in opioid misuse.88 Complementary findings have 
been obtained in a sample of nicotine-dependent smokers 
participating in a pilot functional magnetic resonance imag-
ing (fMRI) study of MORE. This study found that compared 
to a time-matched comparison group, participants in MORE 
demonstrated significant pre- to post-treatment increases in 
striatal and rostral anterior cingulate (rACC) activation dur-
ing savoring of natural rewards that significantly predicted 
reductions in cigarette smoking.89 Together, these findings 
suggest that MBIs may reduce substance use by restructuring 
reward processes.
Decreasing stress reactivity
Decades of research demonstrate stress exacerbates sub-
stance use.90,91 MBIs may ameliorate SUDs and addiction 
relapse through their stress reductive effects. The effects of 
MBIs on stress reactivity and recovery have been indexed 
by HRV, the beat-to-beat variation in heart rate governed by 
a central-autonomic network implicated in the regulation of 
attention and emotion92,93; HRV is considered to reflect the 
capacity to self-regulate stress.94,95 In a RCT, MBRP increased 
HRV for individuals diagnosed with SUDs (alcohol, n=20; 
crack cocaine, n=8; marijuana, n=1;  methamphetamine, n=3; 
Table 3 Experimental studies of the impact of mindfulness on stress reactivity
Study SUD/addictive behavior 
(sample size)
MBI Control condition Results
Carroll & 
Lustyk113
Polysubstance use (N=34) MBRP: 8 weekly, 
2-hour group sessions
Relapse prevention: 8 
weekly, 2-hour group 
sessions TAU
Participation in MBRP was associated with 
higher cardiac vagal control and lower 
stress/anxious reactivity.
Kober et al114 Tobacco use disorder 
(N=23)
Mindfulness training Freedom from Smoking Participants in mindfulness training 
demonstrated lower stress-reactivity 
compared to the control group.
Paz et al115 Tobacco use disorder 
(N=104)
Present moment 
attention and 
awareness training
Cope-as-usual control 
condition
Present moment attention and awareness 
training was associated with reductions 
in psycho-physiological dysregulation in 
response to an axiogenic stressor.
Abbreviations: SUD, substance use disorder; MBI, mindfulness-based interventions; MBRP, mindfulness-based relapse prevention; TAU, treatment-as-usual.
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Heroin, n=2) compared to TAU and a control condition.96 
Similarly, brief mindfulness training has been associated 
with significantly greater HRV increases during exposure to 
stress in a sample of nicotine-deprived smokers.97 In a pilot 
RCT for alcohol use disorder, participants receiving MORE 
demonstrated significantly greater HRV recovery from stress-
primed alcohol cues.80 Extending beyond HRV, a recent 
RCT examined neural mechanisms of mindfulness-induced 
stress regulation. Following 8 weeks of mindfulness training, 
nicotine-dependent smokers demonstrated significantly less 
amygdala and insula activity during stress exposure than 
smokers randomized to a control condition, which predicted 
decreases in smoking 3 months after the intervention.98 
These studies add to a growing body of evidence that MBIs 
decrease stress reactivity, further substantiating that mindful-
ness influences the physiological mechanisms underpinning 
addiction and relapse.
Clinical application of mindfulness 
intervention mechanisms for substance 
use disorder and relapse prevention
First-generation MBIs (ie, MBSR, MBCT) influenced 
the development of contemporary MBIs for addiction (ie, 
MBRP, MORE). Following MBSR, most modern MBIs for 
addiction are structured as 8-week, group therapy programs, 
with a format consisting of guided mindfulness practice and 
debriefing/group process, didactic material, and homework 
assignments to practice mindfulness skills in the context 
of everyday life as a means of coping with stress, negative 
affect, and substance use impulses. Extant MBIs designed 
specifically to intervene in SUD and relapse prevention dif-
fer somewhat from first-generation MBIs in their emphasis, 
didactic content delivered, duration of home mindfulness 
practice, and style of debriefing. Modern MBIs for addiction 
typically provide standard focused attention and open moni-
toring meditations, as well as mindfulness exercises specifi-
cally tailored to address substance craving and substance use 
habits. Below, we discuss general clinical principles for using 
MBIs to intervene in SUD and prevent relapse.
Intervening in substance use disorder
As a result of neurocognitive and interoceptive (ie, aware-
ness of the physiological condition of the body)99 deficits, 
many individuals with SUDs have poor insight into their 
substance use habits and the negative consequences of their 
substance use.100 As a case in point, the current opioid crisis 
emerged, in part, from the prescription of opioid analgesics 
to individuals with chronic pain who were unaware of the 
addiction liability of these drugs.101 Mindfulness practice 
might help such individuals become aware of automaticity 
related to their opioid use. For example, by cultivating mind-
ful awareness during the act of taking medication, a patient 
may begin to notice that she takes higher doses of opioids 
without intending to when she is lonely or dysphoric. Alter-
natively, through mindfulness practice, a patient may become 
aware of escalating use following exposure to opioid-related 
cues and contexts. Whereas before these patients would 
associate increased medication use with increases in pain, 
developing mindfulness through meditation practices may 
lead to the awareness that their increase in medication use 
is, in fact, an attempt to self-medicate aversive emotional 
states or a response triggered by substance-related cues. 
Similarly, a person who considers himself a social drinker 
may realize through mindfulness practice that he is drinking 
more than he intends to, and that his alcohol consumption 
has serious consequences for his life such as an inability to 
focus while at work or being disconnected from his family. 
Thus, in addition to helping individuals with SUDs develop 
insight into their reasons for substance use, mindfulness can 
also reveal consequences associated with substance use; for 
instance, withdrawal symptoms, feelings of shame, relation-
ship problems, and/or deleterious effects on occupational 
or legal status. Furthermore, mindfulness practice can help 
individuals gain awareness of how substance cues trigger 
the experience of craving, resulting in substance use despite 
adverse consequences and the intent to abstain.
Through gaining awareness of substance use patterns, 
automaticity of use, and the extent to which they are self-med-
icating negative affect with substances, individuals can then 
use mindfulness skills to address their SUD symptoms. They 
can utilize techniques like mindful breathing, body scan, 
and mindfulness of everyday life activities to de-automatize 
substance use habits, strengthen self-regulatory capacity, 
and thereby exert greater self-control over their behavior. 
When craving arises, mindfulness practice can deconstruct 
the experience of craving into its cognitive, affective, and 
sensorial components. In so doing, the transitory nature of 
craving is revealed, and one may realize that craving need not 
inexorably lead to substance use. This technique, also known 
as “urge surfing” can reduce craving102 and decouple craving 
from subsequent substance use behavior.103 This technique 
can be potentiated by using mindfulness to consciously con-
template positive consequences of abstaining from substance 
use – a cognitive process that has been shown to downregulate 
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craving responses in the striatum by amplifying prefrontal 
cortical activity.104 For example, a woman with polysubstance 
dependence may be stressed and struggling with whether to 
accept an invitation to attend a party where she knows the 
guests will be using alcohol and drugs. Before she decides to 
attend the party, she could practice mindfulness to decrease 
stress and become aware of any craving-related thoughts, 
feelings, and bodily sensations. If she chooses to attend the 
party, she can use mindfulness to monitor and regulate her 
experience of craving in response to substance-related cues. 
However, if she notices she is feeling overwhelmed with 
craving, she could use mindfulness to disrupt the automatic 
urge to engage in substance use, and then mindfully respond 
by taking steps to decrease her risk (eg, leaving the party and 
calling a supportive friend).
In sum, MM may promote self-awareness and self-regu-
lation of drug-use action schemas, cue-reactivity, substance-
seeking behaviors, and substance consumption. By developing 
trait mindfulness over the course of participating in an MBI, 
an individual with a SUD may become more aware of how 
automatic substance use responses operate in daily life. The 
individual may then evoke the state of mindfulness through 
focused attention or open monitoring mindfulness practice and 
choose to respond with a more adaptive coping strategy. Over 
time, the individual may develop the motivation to reduce 
substance use or abstain entirely, at which point mindfulness 
may be useful for preventing relapse.
Preventing relapse
Given that SUDs are chronically-relapsing conditions,50,58 
any intervention for substance use should acknowledge the 
risk of relapse and take steps for prevention. In addition to 
relapse prevention, individuals with SUDs must also prepare 
for coping with a relapse. The evidence of mindfulness in 
the prevention of relapse is limited by high attrition rates in 
RCTs. For instance, Grant et al’s105 systematic review and 
meta-analysis of nine RCTs of mindfulness-based relapse 
prevention did not detect a statistically significant difference 
across a range of outcomes (eg, relapse, frequency of use, 
intervention dropout, depressive symptoms, anxiety symp-
toms, or mindfulness). However, they did find statistically 
significant differences in favor of MBRP on withdrawal/
craving symptoms and negative consequences of substance 
use. The authors call for higher quality RCTs to evaluate the 
effectiveness of MBIs for relapse prevention.
We argue that mindfulness is particularly suited for 
relapse prevention. To prevent relapse, individuals may be 
able to use mindfulness to cultivate an awareness of when 
substance use habits are triggered by substance cues even 
after an extended period of abstinence. For instance, monitor-
ing their affective state, and knowing that increased stress, 
despair, or anger increases relapse risk, the individual may 
use mindfulness to contemplate the reasons they want to 
maintain their recovery. A clinical vignette may be illustra-
tive. Consider an opioid-misusing chronic pain patient who 
used opioids to self-medicate depression and loneliness. 
After using mindfulness skills to successfully titrate off 
opioids with the help of her primary care provider, she began 
exercise therapy which she found helped with her pain and 
social isolation. One day she has a fall, which landed her in 
the emergency room with a broken ankle. Without knowing 
the patient’s opioid misuse history, the attending physician 
unwittingly prescribes an opioid medication and advises 
the patient to wait several weeks before resuming physical 
activity. As a result of the self-awareness cultivated through 
daily mindfulness practice, the patient may recognize the 
cravings that arise as she holds the prescription slip in her 
hand. To prevent relapse, she might use mindfulness skills 
to deconstruct the experience of craving and contemplate the 
consequences of relapse versus maintaining abstinence. As 
the craving abates, she may choose to not fill the prescrip-
tion, use a non-opioid pain reliever, and attend the exercise 
therapy class for social support even if she cannot participate 
physically in the exercises.
Mindfulness practice may also ameliorate hedonic dys-
regulation and thereby reduce risk for relapse. By practicing 
mindfulness to savor everyday pleasant activities, an indi-
vidual in recovery from a SUD can self-generate feelings of 
contentment, relaxation, and joy. Consider an individual with 
cocaine use disorder in full remission who practices mindful 
savoring when his grandchildren visit on the weekend. By 
using mindfulness to focus on the positive emotions and the 
sense of meaningfulness that emerge from spending time with 
his grandchildren, this individual may feel more satisfied and 
contented than he ever did when using substances. Consis-
tent with the reward restructuring hypothesis, by practicing 
mindful savoring over time, the experience of natural reward 
may outweigh the drive to use drugs to obtain a sense of well-
being – fortifying the individual against relapse.
Mindfulness training may also be helpful if a relapse 
occurs. Consider the case of a man in partial remission from 
alcohol use disorder who has recently stopped drinking. After 
successfully abstaining from alcohol for over 2 months after 
realizing the negative impact his drinking had on his fam-
ily and work, he attends a party with old friends, where he 
is overcome by craving and has a drinking lapse. He could 
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interpret this lapse as the beginning of a downward spiral 
into his alcohol use habits, with attendant feelings of shame 
and hopelessness. Alternatively, he could use mindfulness 
to disengage from this negative emotional state, arrest the 
automatic impulse and concomitant experience of craving, 
and then re-commit himself to recovery by contacting his 
12-Step fellowship sponsor. Thus, mindfulness may help to 
prevent relapse by increasing awareness of high-risk situ-
ations, supporting positive hedonic tone, and preventing a 
singular lapse from becoming a full-blown relapse.
Discussion
More than a decade of research has demonstrated the promise 
of MBIs for intervening in SUDs and preventing relapse. 
Although rigorous trials have been conducted, a number of 
these studies have methodological limitations that limit the 
ability to conclusively affirm the effectiveness of mindful-
ness intervention with SUDs and prevention of relapse. For 
instance, Sancho et al’s16 recent systematic review raises the 
concern that MBI intervention effects do not seem to persist 
at follow-up assessment. Thus, there remains a need for more 
large-scale, robust RCTs to reveal the clinical outcomes and 
therapeutic mechanisms of MBIs for addiction.
Recently, a number of frontiers for research on MBIs have 
been outlined, including issues pertaining to intervention 
sequencing, dose-response relationships, and implementation 
science.103 Mindfulness might be integrated into standard 
cognitive-behavioral interventions for addiction, indeed 
Bowen et al43 found that MBRP is superior to relapse pre-
vention without mindfulness. Further, Garland et al40 found 
that MORE is superior to CBT. More studies are needed to 
determine which of these components are driving interven-
tion effects and perhaps, in what order the components are the 
most effective. For example, the mindful reappraisal hypoth-
esis states that mindfulness training may prepare people to 
learn and practice cognitive restructuring.106
More studies are needed to determine which of these com-
ponents are driving intervention effects and perhaps, in what 
order the components are the most effective. For example, 
the mindful reappraisal hypothesis states that mindfulness 
training may prepare people to learn and practice cognitive 
restructuring.106
With regard to implementation science, many studies 
to date have measured the effectiveness of brief MBIs due 
to their relative ease of dissemination. Yet, to be optimally 
efficacious, future intervention development research might 
consider evolving MBIs beyond a time-limited intervention 
approach. Despite growing pressure for expediency and 
increasingly brief intervention, SUDs are chronic conditions 
that may require prolonged interventions to produce durable 
change. In that regard, mindfulness might be conceptualized 
as an integral component of a wellness-oriented lifestyle – 
a catalyst for long-term recovery. Using physical health as 
an analogy, maintaining a healthy diet and regular exercise 
across the lifespan is integral to wellbeing. Similarly, mind-
fulness might need to be practiced on a near daily basis for 
many years to effectively intervene in addiction and prevent 
relapse. Research is needed to test the comparative effective-
ness of brief versus extended MBIs and the relative cost-
effectiveness of these models. Given interest in internet- and 
app-delivered mindfulness interventions, research is needed 
to determine whether the low dose, brief format of these 
delivery systems is sufficient to intervene in the chronically 
relapsing symptoms of SUD.107,108 However, if long-term 
MBIs are shown to produce the greatest clinical benefit, 
their implementation would require significant change in the 
current addiction treatment system. Yet, the emerging global 
emphasis on integrative health supports a holistic approach 
toward wellness by providing treatment for psychiatric 
and SUDs in community-based medical settings. MBIs, in 
brief and extended formats, may be uniquely suited to this 
therapeutic context, and in time, may become mainstays of 
addiction treatment.
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